9 terminated. 9 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Basiliximab: new trials by email Literature Review of Basiliximab trials Research Report on Basiliximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen Anti-thymocyte Globulin (Rabbit), belatacept, methylprednisolone - Primary Renal Allograft Candidate, Kidney Transplantation | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 71 | 2013-07-01 | 2026-09-24 |
| Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease Infliximab and Basiliximab - Graft Versus Host Disease, Steroid Refractory GVHD | Phase 2 | Terminated | Nationwide Children's Hospital | 11 | 2011-12-01 | 2019-04-05 |
| Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation Alemtuzumab, MMF, Basiliximab - Kidney Transplantation, Renal Transplantation | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 19 | 2011-09-01 | 2026-09-24 |
| Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant basiliximab - End Stage Renal Disease | Phase 2 / Phase 3 | Terminated | Drexel University College of Medicine | 5 | 2009-05-01 | 2015-02-10 |
| The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis Basiliximab, Placebo - Non-infectious Uveitis | Phase 2 | Terminated | Cerimon Pharmaceuticals | 5 | 2008-05-01 | 2010-08-19 |
| Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance Mesenchymal stem cells infusion, Basiliximab,Methylprednisolone,RATG ,Cyclosporine ,Mycophenolate mofetil, Basiliximab, Methylprednisolone,RATG,Cyclosporine,Mycophenolate mofetil - Kidney Transplant | Phase 1 / Phase 2 | Terminated | Mario Negri Institute for Pharmacological Research | 4 | 2008-05-01 | 2023-12-04 |
| Belatacept in Liver Transplant Recipients Tacrolimus, Basiliximab, Belatacept More Intensive (MI) - Immunosuppression in Solid Organ Transplant | Phase 2 | Terminated | Bristol-Myers Squibb | 260 | 2008-01-01 | 2012-10-18 |
| Basiliximab Maintenance in Ulcerative Colitis Basiliximab - Ulcerative Colitis | Phase 2 | Terminated | Cerimon Pharmaceuticals | 88 | 2007-07-01 | 2010-02-04 |
| Steroid Withdrawal in Pediatric Kidney Transplant Recipients Basiliximab, Cyclosporine, Tacrolimus - End-Stage Renal Disease | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 274 | 2001-01-01 | 2016-10-21 |
Kidney Failure, Chronic (2) · Colitis, Ulcerative (1) · Graft vs Host Disease (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Cerimon Pharmaceuticals (2) · Bristol-Myers Squibb (1) · Drexel University College of Medicine (1) · Mario Negri Institute for Pharmacological Research (1) · Nationwide Children's Hospital (1)
United States (7) · Italy (2) · Argentina (1) · Austria (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Mexico (1) · Spain (1) · United Kingdom (1)
Kenneth Newell, MD, PhD (2) · Alessandro Rambaldi, MD (1) · Christian P. Larsen, MD, DPhil (1) · Giuseppe Remuzzi, MD (1) · Marina Noris, CH Ph (1) · Martino Introna, MD (1) · Mysore Anil S. Kumar, MD (1) · Norberto Perico, MD (1) · Rajinder S Bajwa, MD (1) · Roslyn B. Mannon, M.D. (1) · Shaily J. Reichert (1) · Shaily Reichert (1) · William Harmon, MD (1)
PMID 18416737, PMID 19663893, PMID 20930086, PMID 23738760, PMID 25041339, PMID 28556519, PMID 29963053, PMID 32558199
2009 (1)